Camel milk proteins contain dipeptidyl peptidase IV (DPP-IV) inhibitory peptides. A camel whey protein concentrate (WPC， 44.7 ± 3.4% (w/w) protein) was prepared and subsequently hydrolysed with trypsin at different temperatures， enzyme to substrate (E:S) ratios and hydrolysis times yielding fifteen hydrolysates (H1-H15). Their DPP-IV half maximal inhibitory concentrations (IC) ranged from 0.55 ± 0.05 to 1.52 ± 0.16 mg L for H8 and H6， respectively. E:S was the only factor having a significant effect on the DPP-IV IC value (p < 0.05). Relatively potent α-lactalbumin-derived DPP-IV inhibitory peptides (LAHKPL and ILDKEGIDY) were detected in selected hydrolysates. Additionally， three potent β-CN-derived peptides， VPV， YPI and VPF having DPP-IV IC values of 6.6 ± 0.5， 35.0 ± 2.0 and 55.1 ± 5.8 µM， respectively， were identified. After IPI， VPV is the second most potent DPP-IV inhibitory peptide identified to date， which supports the role of camel milk as an antidiabetic agent.